Table 2 Response to initial bevacizumab treatment regimen compared by choroidal thickness and presence of pachyvessels
pachyvessels | Choroidal thickness above/bellow 250 µ | Choroidal thickness above/bellow 300 µ | |
|---|---|---|---|
Change in VA after 3 monthly injections (LogMar) | No − 0.24 ± 0.38 (P = 0.19) | < 250 µ − 0.13 ± 0.33(P = 0.77) | < 300 µ − 0.12 ± 0.30(P = 0.62) |
Yes − 0.081 ± 0.32(p = 0.19) | > 250 µ − 0.10 ± 0.34(P = 0.77) | > 300 µ − 0.06 ± 0.46(P = 0.62) | |
Change in CMT after 3 monthly injections (µ) | No − 119.3 ± 110.2 (P = 0.24) | < 250 µ − 91.63 ± 102.9(P = 0.57) | < 300 µ − 78.9 ± 103.4(P = 0.53) |
Yes − 75.7 ± 102.4 (P = 0.24) | > 250 µ − 73.85 ± 106.7(P = 0.57) | > 300 µ − 104.2 ± 110.07(P = 0.53) |